Herein, immunosuppressive mechanisms of tumor NOS2/COX2 expression were spatially explored using multiplex immunofluorescence imaging of 20 ER– tumors from patients who succumbed to disease (deceased; n = 10) versus those who survived (alive; n = 10) at 5 years after diagnosis. The gene discussed is NOS2; the disease is neoplasm.